290 results found for '谷歌学术搜索引擎主页,yahoo exchange rate,战地1xbox360咨询QQ:4826193'.
Targeted innovation and better access to vector control tools essential in Asia Pacific
News | 31 January 2018
...Benjamin Rolfe, CEO of APLMA. This event was an opportunity to bring together participants across different sectors, including industry representatives, for open discussions on ways to accelerate innovation. During a...
World Hepatitis Day: Unitaid is pioneering urgent solutions to tackle hepatitis C
News | 27 July 2023
...complex, severely hinder the reach of new drugs. Add to that the fact that populations with the highest rates of hepatitis C – people who inject drugs or those who...
Johnson & Johnson pricing agreement for critical TB drug still unfairly restricts access in countries where the need is greatest
News | 29 September 2023
Open letter from Unitaid’s Executive Director calls on the drug company to drop secondary patents for the drug-resistant TB (DR-TB) medicine bedaquiline, and to make negotiated rates available to all...
Unitaid adopts an ambitious new five-year strategy at the 40th Executive Board meeting
News | 16 June 2022
...innovation. With the introduction of at least 30 game-changing new health products by 2030, Unitaid will accelerate the global response to combat HIV/AIDS, tuberculosis (TB) and malaria, and improve the...
Unitaid supports ANTICOV, an adaptative platform trial in Africa to treat mild to moderate cases of COVID-19
News | 24 November 2020
...led by Drugs for Neglected Diseases Initiative (DNDi) including 26 African and global research and development organizations. It seeks to identify treatments that prevent patients with mild to moderate symptoms...
Solutions identified to enable affordable medicines for hepatitis C, Unitaid new report highlights
News | 12 February 2015
...Médecins Sans Frontières (MSF) to demonstrate the feasibility of treating hepatitis C with these new medicines in resource limited settings, including through reducing prices. The UNITAID report highlights interlinked ways...
Unitaid welcomes new agreements from CHAI to accelerate access to affordable COVID-19 antiviral nirmatrelvir/ritonavir in low- and middle-income countries
News | 13 May 2022
...for mild-to-moderate COVID-19 patients at high risk of developing severe forms of the disease, when administered in early stages of the infection. These agreements represent an important step in the...
The ATLAS project in West Africa: a big innovation at local level to achieve the global HIV screening goal by 2020
News | 29 January 2019
...Central Africa, as a way to achieve high rates of HIV screening and thus help to reverse the epidemic trend”, explained Unitaid Executive Director Lelio Marmora. Knowing HIV serological status...
Next generation pulse oximeters have great potential to reduce maternal and child mortality, PATH and Unitaid report says
News | 12 September 2022
A technology and market landscape report by PATH and Unitaid To date, maternal and child mortality rates remain unacceptably high. In 2020, still over 5 million children under 5 years...
Cost of rapid COVID-19 tests halved as global investment ensures availability of high volumes for low- and middle-income countries
News | 22 January 2021
...have often left healthcare providers unable to access urgently needed tests. While high-income countries are now conducting 252 tests per 100,000 people each day, in LMICs the rate is 10...